InflaRx (IFRX) Shares Outstanding (Weighted Average) (2022 - 2025)

InflaRx (IFRX) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $78.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 24.4% to $78.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.3 million through Dec 2025, up 24.4% year-over-year, with the annual reading at $78.3 million for FY2025, 24.4% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $78.3 million in Q4 2025 for InflaRx, up from $63.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $78.3 million in Q4 2025 to a low of $45.6 million in Q4 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $61.5 million across 4 years, with a median of $61.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 29.61% in 2023 and later rose 6.51% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $45.6 million in 2022, then increased by 29.61% to $59.1 million in 2023, then grew by 6.51% to $63.0 million in 2024, then grew by 24.4% to $78.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for IFRX at $78.3 million in Q4 2025, $63.0 million in Q4 2024, and $59.1 million in Q4 2023.